Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|33|5954-5962

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.33, 2013-10, pp. : 5954-5962

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential Use of Dendritic Cells for Anti-Atherosclerotic Therapy

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5873-5882

Bentham Science Publishers

Access to resources Recommend Favorite

Direct Anti-Atherosclerotic Therapy; Development of Natural Anti-Atherosclerotic Drugs Preventing Cellular Cholesterol Retention

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5909-5928

Bentham Science Publishers

Access to resources Recommend Favorite

Phytoestrogen-Rich Dietary Supplements in Anti-Atherosclerotic Therapy in Postmenopausal Women

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 152-163

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Novel Targets and Biomarkers for Anti-atherosclerotic Therapy)

By  

Current Pharmaceutical Design, Vol. 19, Iss. 33, 2013-10 ,pp. : 5837-5839

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Mechanisms of Atherogenesis and Development of Anti-Atherosclerotic Therapy)

By  

Current Pharmaceutical Design, Vol. 21, Iss. 9, 2015-03 ,pp. : 1103-1106

Bentham Science Publishers

Access to resources Recommend Favorite